immg_1512g.htm

0001640334-17-001298.txt : 20170622 0001640334-17-001298.hdr.sgml : 20170622 20170621175155 ACCESSION NUMBER: 0001640334-17-001298 CONFORMED SUBMISSION TYPE: 15-15D PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20170622 DATE AS OF CHANGE: 20170621 EFFECTIVENESS DATE: 20170622 FILER: COMPANY DATA: COMPANY CONFORMED NAME: IMMAGE BIOTHERAPEUTICS CORP. CENTRAL INDEX KEY: 0001564273 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 455538945 STATE OF INCORPORATION: NV FISCAL YEAR END: 0831 FILING VALUES: FORM TYPE: 15-15D SEC ACT: 1934 Act SEC FILE NUMBER: 333-185368 FILM NUMBER: 17923640 BUSINESS ADDRESS: STREET 1: 10411 MOTOR CITY DR., SUITE 750 CITY: BETHESDA STATE: MD ZIP: 20817 BUSINESS PHONE: (443) 961-1185 MAIL ADDRESS: STREET 1: 10411 MOTOR CITY DR., SUITE 750 CITY: BETHESDA STATE: MD ZIP: 20817 FORMER COMPANY: FORMER CONFORMED NAME: EPICURE CHARCOAL, INC. DATE OF NAME CHANGE: 20121210 15-15D 1 immg_1515d.htm 15-15D immg_1512g.htm

OMB APPROVAL

OMB Number: 3235-0167

Expires: March 31, 2018

Estimated average burden hours per response….1.50

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 15

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

Commission File Number: 333-185368

IMMAGE BIOTHERAPEUTICS CORP.

(Exact name of registrant as specified in its charter)

10411 Motor City Dr., Ste. 750, Bethesda, MD 20817

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

Common Stock ($0.001 par value per share)

(Title of each class of securities covered by this Form)

None.

(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

Rule 12g-4(a)(1)

x

Rule 12g-4(a)(2)

o

Rule 12h-3(b)(1)(i)

o

Rule 12h-3(b)(1)(ii)

o

Rule 15d-6

o

Rule 15d-22(b)

o

Approximate number of holders of record as of the certification or notice date: 6

Pursuant to the requirements of the Securities Exchange Act of 1934, Immage Biotherapeutics Corp. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

Date:

June 21, 2017

By:

/s/ Mahesh Narayanan

Mahesh Narayanan

President and Chief Operating Officer

		OMB APPROVAL
		OMB Number: 3235-0167
		Expires: March 31, 2018
		Estimated average burden hours per response….1.50

IMMAGE BIOTHERAPEUTICS CORP.
(Exact name of registrant as specified in its charter)

10411 Motor City Dr., Ste. 750, Bethesda, MD 20817
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

Common Stock ($0.001 par value per share)
(Title of each class of securities covered by this Form)

None.
(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

	Rule 12g-4(a)(1)		x
	Rule 12g-4(a)(2)		o
	Rule 12h-3(b)(1)(i)		o
	Rule 12h-3(b)(1)(ii)		o
	Rule 15d-6		o
	Rule 15d-22(b)		o


Date:	June 21, 2017	By:	/s/ Mahesh Narayanan
			Mahesh Narayanan
			President and Chief Operating Officer